Atlas Trials

Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?

Clinical trial NCT01373125 · COMPLETED

Trial details

NCT number
NCT01373125
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Study type
OBSERVATIONAL
Barrett's EsophagusIntestinal MetaplasiaGastroesophageal Reflux Disease (GERD)
Start date
2011-06-01
Primary completion
2014-10-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.